We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.125 | 0.69% | 18.125 | 17.75 | 18.50 | 18.125 | 18.00 | 18.00 | 125,995 | 13:24:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.38 | 16.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/3/2018 16:57 | Trotters it was not personal. It has taken longer than I expected as well, hence my 9 months behind my expectations comment earlier today that JJ had issue with. I said back in November I thought there would be buying opportunities in Jan 18. This was Elrico’s reply then to me. “IMHO I don't see any reasons to support your view we will have "plenty of top up opportunities well into jan 2018" because 2018 will dawn a renewed "big push" for SlimBiome, which will be driven with a new marketing and PR campaign by the same company that arguably brought Benecol into the commercial light.” And yet when I point that I believe things are taking longer than expected I’m a deramper and negative. There are still buying opportunities now. And there will be until news comes. | imnotlong | |
27/3/2018 16:52 | On the plus side there has been good volume today. The problem is alot of people buy the news and will ditch these over the coming weeks as boredom sets in and the share price stagnates I cannot see a sustained rise until hard numbers are presented on the balance sheet. Apologies for sounding bearish, but it is getting tedious | zebbo | |
27/3/2018 16:44 | imnotlong27 Mar '18 - 15:03 - 33652 of 33659 (Filtered) crikey .. soon be more filtered here than not | onedayrodders | |
27/3/2018 16:43 | How sad trolling back through someone's posts to gain a brownie point. | onedayrodders | |
27/3/2018 16:38 | IMN :) TT, What research? All you do is ramp the guts out of it! Oh and I'm long | judijudi | |
27/3/2018 16:28 | Yes it's taken longer than expected, so what? At least I'm prepared to stick my neck on the block and add value with my research, what do you bring to the party accept negativity and snide comments? | trotterstrading | |
27/3/2018 16:17 | Trotters, re your comment about weak hands kicking themselves in the next few months.... Similar to this from over a year ago? Still just a bit a patience required. “TrottersTradi Nice one Primal. great response from SoH. Just a bit of patience required folks. Make no mistake OPTI could be the share of 2017 IMHO” | imnotlong | |
27/3/2018 15:38 | The share doesn't need ramping.. But we will anyway. You cannot make this stuff up. | monkeywench1 | |
27/3/2018 15:21 | More weak hands cleared, boy are they going to be kicking themselves in a few months | trotterstrading | |
27/3/2018 15:03 | Good post Risky. It does beg the question why the share price is where it is considering the investment proposition is so compelling, even if somewhat complex. I’m sure by now some clever analysts working for II’s should have worked it out and decided to invest in a company that’s declares itself to be‘global leaders in targeted microbiome modulation and sweet prebiotics/fibres | imnotlong | |
27/3/2018 13:49 | This share does not need ramping, though it appears to require to give constant reminders to educate those to what it is the company is actually in the process of doing.To be fair the model is extraordinary. Opti is currently in limbo stage where it is transitioning to a commercial operation rather than a loss making R&D company. The market demands numbers though the company believes it to be too much of a risk to accurately forecast at this moment in time due to its growing list of clients that are launching products and paying at different times throughout the year. The bod have given an indication to the value of the deals multiple times now. The dots are all there to be joined.....hugely experienced bod with big contacts within industry, industry leaders set up as manufacturing partners, global industry leading events shortlisting Optis products for best technology/products, low cost £80-£90k cash burn, growing pipeline of license deals with the number of launches by these partners increasing globally and not to mention Skinbio which mitigates Optis need to ever raise another penny of cash to cover its costs before it becomes profitable. Times like these the brain can actually come in use. | riskybusiness1 | |
27/3/2018 13:32 | Well done to you tightfist. That's a great result. Re the growth to come, let's hope so, for all of our sales. John | 2350220 | |
27/3/2018 13:18 | Trading statements like this mornings just won't cut the muster anymore and produce even a temporary rise in the share price. They need to produce figures and projections. Cash is dwindling as each day passes, and the signs suggest that profitability and cash flow break-even continue to be some way off for the foreseeable. How long before a cash call and at what price? At the moment it appears that everything I've said for the past two years is coming to fruition. The chart is telling it's own story. Maybe the results in April will reverse the negativity, but I won't hold my breath. As ever AIMHO DYOR etc. | michaelmouse | |
27/3/2018 12:35 | 235/John,There are two many loose holders for a rise to stick, we need to be content that the 56/57p level holds for now, the macro-climate isn't helpful at present either.IMO I am very confident that in 6-12 months time we will be well North of here, just as TT describes. With four potential companies each comprising multiple potential initiatives/partners | tightfist | |
27/3/2018 12:21 | Bought in last week - both the shares and the product. I've got 3 weeks worth of Gofigure stuff just arrived (don't think I'll be wolfing it down over Easter though). At first glance it looks a bit too much like an expensive but slightly more appealing version of Slimfast - I work with a very lardy lady who's tried and failed with slimfast over the years - I don't know anyone who's kept weight off after using that stuff so it's not the best association. Perhaps they should try to tap into the 5:2 diet trend - could be a good way of making the hungry fasting days more achievable. I only want to lose 3 or 4 kilos - let's see how it goes. At worst, it's £100 of turnover for the company... | verulamium | |
27/3/2018 12:17 | Blimey, that very positive RNS hasn't helped. I didn't expect 'take off', but I really didn't expect us to drop either. John | 2350220 | |
27/3/2018 12:16 | Oh dear Vanduke,Dont get me wrong but that 46k (so far the biggest chunk of the day) looked like a buy to me?But I'm guessing you and your syndicate know better? Sienna : ) | siennadelekat21 | |
27/3/2018 12:14 | I'm right in thinking Monkey is Michaelmouse, right? The one who lost everything and has been obsessively posting here for a few years now... | loungeact | |
27/3/2018 12:12 | Rathean27 Mar '18 - 08:41 - 33612 of 33623 Do you really think now is a good time to distribute currently bombed out SBTX shares ? They will wait until market cap is much higher and I'm happy for them to do that. | onedayrodders | |
27/3/2018 11:58 | Rampers love to lose money. | monkeywench1 | |
27/3/2018 11:57 | 30k sold at 53p.Oh dear.Big blocks sells..small are buyers.Where are those famous II buyers.. | vanduke | |
27/3/2018 11:50 | Only from one aspect judi. Oh and btw, they are fine! :) | rayrac | |
27/3/2018 11:50 | Call me old fashioned, but I prefer my shares to make a profit. | nimrod22 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions